Matches in Nanopublications for { ?s ?p "[Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP857248.RAi-sirQFC235t2o4nItJ89WrU57E6wOSyZPLvqp1gQu4130_assertion description "[Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857248.RAi-sirQFC235t2o4nItJ89WrU57E6wOSyZPLvqp1gQu4130_provenance.
- assertion description "[Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_assertion description "[Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.
- NP380572.RAas_-zVnC_49uhysiwHe3AyFCEMRzb6eWpgxvjV_QeL0130_assertion description "[Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380572.RAas_-zVnC_49uhysiwHe3AyFCEMRzb6eWpgxvjV_QeL0130_provenance.
- NP795643.RAeFTkyd5-2Fn4ZQDgpmUAGQNSNUHtnq7MhmwEl2ae0Mc130_assertion description "[Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795643.RAeFTkyd5-2Fn4ZQDgpmUAGQNSNUHtnq7MhmwEl2ae0Mc130_provenance.
- NP795645.RAJ0ML9aABLsiiOTn_CnQIWlmPS79Lw0oaEqnUlgYTgcI130_assertion description "[Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795645.RAJ0ML9aABLsiiOTn_CnQIWlmPS79Lw0oaEqnUlgYTgcI130_provenance.